Tous Actualités
Suivre
Abonner LifeWatch AG

LifeWatch AG

EANS-Adhoc: LifeWatch Announces the World's First iPad ECG Report Viewers

  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
New Products/LifeWatch AG
11.05.2010
Chicago, IL / USA May 11 2010 -LifeWatch Services, Inc., a subsidiary
of LifeWatch AG (SIX Swiss Exchange: LIFE), will announce the launch 
of their remote ECG report TeleViewer application for the Apple iPad.
The iPad application integrates with and enhances the advanced 
reporting and workflow management capabilities present in their web 
based applications for all product offerings. The LifeWatch 
TeleViewer will also be part of their newly announced series of 
remote patient monitoring service packages called TeleClinics. The 
iPad's ease-of-use, portability, convenience and multi-touch 
capabilities are well suited to the timely review of patient remote 
monitoring reports that provide comprehensive and actionable 
information for Physicians. These features will help physicians 
increase their productivity and standard of care through a 
streamlined work flow and immediate access to critical patient data 
that enables faster diagnosis and better treatment options, and to 
this end, helps eliminate unnecessary and costly hospitalizations and
readmissions.
LifeWatch's TeleViewer can help reduce risk of error as patient care 
is increasingly handed off from one doctor to another. It makes 
keeping in touch with LifeWatch and the patient a simple and easy 
task. The physician benefit is increased productivity, streamlined 
work and data flow making more time for patient care.
The TeleViewer takes advantage of the large iPad screen to produce 
clear and accurate viewing images of both reports and ECG strips.
The new (Atrial Fibrillation) AF TeleClinic that is being announced 
this week at the Heart Rhythm Society meeting in Denver will be 
available on the TeleViewer. LifeWatch will provide iPad TeleViewers 
to physicians enrolled in the AF TeleClinic service. AF TeleClinic is
a treatment-focused service package that provides a standard panel of
monitoring tests at pre-set intervals and advanced analysis reporting
tools for post- procedure AF patients.
LifeWatch is focusing on ability to deliver the remote patient 
monitoring data to physicians and clinicians anytime, anywhere.
"Bringing the iPad's innovative multi-touch apps and the e-book 
reader functionality to the medical community makes it perfect for 
enabling physicians to review and read reports on their patients 
being monitored remotely", stated Brent Cohen, CEO ,LifeWatch AG." 
Other versions of the TeleClinic using the TeleViewer will be 
launched in the near future, including TeleClinics for Stroke, 
Syncope and Obstructive Sleep Apnea management."
About LifeWatch AG:
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on 
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare 
technology and solution company, specializing in advanced telehealth 
systems and wireless remote patient monitoring services. LifeWatch 
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the 
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent 
company of LifeWatch Services Inc., a leading US-based cardiac 
monitoring service provider, and manufacturer of telecardiology 
products. LifeWatch is also introducing a new program for Home 
SleepTesting of Obstructive Sleep Apnea (OSA) patients under the 
brand name NiteWatch. For additional information, please visit 
{www.lifewatch.com}[HYPERLINK: http://www.lifewatch.com] and 
{www.nitewatchservices.com}[HYPERLINK: 
http://www.nitewatchservices.com]
Sign-up for customized E-mail alerts and documentation requests is 
available at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All 
statements other than statements of historical facts contained in 
this press release, including statements regarding future results of 
operations and financial position, business strategy and plans and 
objectives for future operations, are forward-looking statements. The
words "believe," "may," "will," "estimate," "continue," "anticipate,"
"intend," "expect" and similar expressions are intended to identify 
forward-looking statements. LifeWatch AG has based these 
forward-looking statements largely on current expectations and 
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business 
strategy, short term and long term business operations and 
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking 
events and circumstances described may not occur and actual results 
could differ materially and adversely from those anticipated or 
implied in the forward-looking statements. All forward-looking 
statements are based only on data available to LifeWatch AG at the 
time of the issue of this press release. LifeWatch AG does not 
undertake any obligation to update any forward-looking statements 
contained in this press release as a result of new information, 
future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF 
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR 
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES.  THIS 
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN 
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH 
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE 
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN 
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE 
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. 
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.  ANY 
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG 
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED 
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL 
STATEMENTS OF THE ISSUER.
Apple is a trademark of Apple Inc., registered in the U.S. and other 
countries. iPad is a trademark of Apple Inc.
end of announcement                               euro adhoc

Further inquiry note:

Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 24 48 | Email
{wkim@lifewatch.com}[HYPERLINK: mailto:wkim@lifewatch.com]

Sensus Investor and Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade

Plus de actualités: LifeWatch AG
Plus de actualités: LifeWatch AG
  • 11.05.2010 – 06:55

    EANS-Adhoc: LifeWatch Announces New "AF TeleClinic"

    ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. New Products/LifeWatch AG 11.05.2010 First in Series of Treatment-Specific Remote Patient Monitoring Services Chicago, IL / USA May 11 2010 - LifeWatch Services, Inc., a subsidiary of LifeWatch AG (SIX Swiss Exchange: LIFE), will unveil its advanced ...

  • 11.05.2010 – 06:50

    EANS-Adhoc: LifeWatch AG to announce departure of Reuven Freudinger

    ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/LifeWatch AG 11.05.2010 Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE), the leading wireless remote cardiac and medical patient monitoring service ...

  • 11.05.2010 – 06:46

    EANS-Adhoc: LifeWatch reports on results for the First Quarter 2010

    ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 3-month report/LifeWatch AG Q1 2010 11.05.2010 • Ongoing positive cash flow • ACT patient enrollments up 37% to 21,099 patients • The first 300 patient enrollments for the NiteWatch service • Additions of managers with proven track record to LifeWatch ...